Belgian experts will introduce the evolving landscape of lung cancer treatment, focusing on treatment sequencing and long-term disease management. Drawing on recent international evidence and their own clinical experience, they will discuss how treatment strategies can be tailored to individual patients and how the growing importance of long-term disease control is changing clinical practice, per specific topic.